高安动脉炎缺血性并发症:一项荟萃分析
该荟萃分析检索MEDLINE、EMBASE和Cochrane图书馆至2016年3月,纳入35项观察性研究、共3262例高安动脉炎(TAK)患者,估算严重缺血性并发症的合并比例。结果显示,TAK病程中卒中合并患病率为8.9%(95%CI:7.0-10.9%),心肌梗死(MI)为3.4%(95%CI:2.1-4.8%),研究间存在中至重度异质性(卒中I²=64.9%;MI I²=74.0%)。作者认为卒中和MI在TAK患者中常见,需进一步研究以识别预测因素和预防措施。
要点
- TAK患者病程中卒中合并患病率为8.9%(95%CI:7.0-10.9%),MI为3.4%(95%CI:2.1-4.8%)。
- 纳入35项观察性研究、共3262例TAK患者,研究质量低至中等。
- 卒中研究间异质性I²=64.9%,MI研究间异质性I²=74.0%,为中至重度异质性。
核心结论
- 卒中和MI在高安动脉炎患者中常见。
- 需进一步研究以识别TAK患者严重缺血事件的预测因素和预防措施。
研究设计与样本
- 本研究为荟萃分析,检索MEDLINE、EMBASE和Cochrane图书馆自建库至2016年3月的文献。
- 纳入报告至少一种严重缺血性并发症的文章,共35项研究、3262例TAK患者。
- 所有纳入研究均为观察性研究,质量低至中等。
- 采用逆方差加权的随机效应模型估算TAK患者缺血性并发症的合并比例。
主要发现
- TAK患者症状发作或诊断时平均年龄范围为10至49岁,症状发作至诊断的平均延迟范围为2个月至7.6年。
- 研究随访时间范围为22个月至17年,大多数研究女性受试者占比超过70%。
- TAK病程中任何时间卒中合并患病率为8.9%(95%CI:7.0-10.9%)。
- TAK病程中任何时间MI合并患病率为3.4%(95%CI:2.1-4.8%)。
- 研究间存在中至重度异质性:卒中I²=64.9%,MI I²=74.0%;其他缺血性并发症报告不一致。
关键数值与推荐
- 卒中合并患病率8.9%(95%CI:7.0-10.9%),基于35项研究、3262例TAK患者。
- MI合并患病率3.4%(95%CI:2.1-4.8%),基于35项研究、3262例TAK患者。
- 卒中异质性I²=64.9%,MI异质性I²=74.0%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 所有纳入研究均为观察性研究,质量低至中等。
- 卒中研究间异质性I²=64.9%,MI研究间异质性I²=74.0%,为中至重度异质性。
- 其他缺血性并发症报告不一致。
- 需进一步研究以识别TAK患者严重缺血事件的预测因素和预防措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Takayasu's arteritis (TAK) is a rare vasculitis affecting the large blood vessels with significant morbidity and mortality from ischemic complications. The objective of this meta-analysis is to determine the proportion of TAK patients with severe ischemic complications. METHODS: We performed a literature search using MEDLINE, EMBASE, and the Cochrane library from database inception to March 2016. We included articles that reported at least one severe ischemic complication. A random effects model with inverse-variance weighting was performed to estimate the pooled proportion of TAK subjects with ischemic complications. RESULTS: In all, 35 studies met inclusion criteria, representing 3262 TAK patients. All studies were observational and of low to moderate quality. Mean age at symptom onset or at diagnosis ranged from 10 to 49 years and mean delay from symptom onset to diagnosis ranged from 2 months to 7.6 years. Study follow-up times were from 22 months to 17 years. The majority of studies had >70% female subjects. The pooled prevalence of stroke in TAK was 8.9% (95% CI: 7.0-10.9%) and of MI was 3.4% (95% CI: 2.1-4.8%) at any time during the disease course. There was moderate-to-severe heterogeneity across the studies (stroke: I2 = 64.9%; MI: I2 = 74.0%). Other ischemic complications were inconsistently reported. CONCLUSION: Stroke and MI are common in TAK patients. Further studies are needed to identify predictors and preventative measures for severe ischemic events in TAK patients.
引用
- Kim H, Barra L. Ischemic complications in Takayasu's arteritis: A meta-analysis. Semin Arthritis Rheum. 2017. PMID: 29198409. doi:10.1016/j.semarthrit.2017.11.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。